UC Asset LP Reports Significant Loss, Concerning Liquidity, and Internal Governance Breach
summarizeSummary
UC Asset LP reported a significant net loss and low cash reserves for 2025, alongside a serious undisclosed conflict of interest involving a General Partner member and a key tenant. This comes as the company focuses on cannabis real estate, an industry poised for potential growth due to recent federal reclassification.
check_boxKey Events
-
Significant Financial Deterioration
The company reported a net loss of $339,596 in 2025, a sharp decline from a $132,410 profit in 2024. Total revenue decreased from $405,168 to $225,163, while operating expenses more than doubled to $553,915.
-
Concerning Liquidity and Increased Debt
Cash reserves at year-end 2025 were $41,765, which management deemed a 'concerning level.' Total debt significantly increased from $109,926 in 2024 to $1,018,000 in 2025.
-
Governance Breach by General Partner Member
Jason Cunningham, a member of the General Partner, failed to disclose the sale of his ownership in Fire Ranch LLC (a key tenant) in January 2025 before brokering a new 5-year lease deal with the company's subsidiary in April 2025. Actions are being taken against Cunningham.
-
Strategic Shift to Cannabis Real Estate
The company has fully shifted its primary business focus to investing in cannabis cultivation properties, reporting a 13.6% cash-by-cash ROI on its cannabis portfolio in 2025.
auto_awesomeAnalysis
This annual report reveals a substantial net loss and a concerning cash position, highlighting financial distress. A critical governance issue emerged with a General Partner member failing to disclose a conflict of interest related to a key tenant, leading to internal actions. While the company pivots to cannabis real estate, a recent federal reclassification of medical cannabis offers a potential long-term tailwind for the industry.
At the time of this filing, UCASU was trading at $0.26 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $1.4M. The 52-week trading range was $0.01 to $3.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.